Glucopon 215 UP
General Information
Mainterm | Glucopon 215 UP |
CAS Reg.No.(or other ID) | 68515-73-1 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 3033856 |
IUPAC Name | (3R,4S,5S,6R)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol |
InChI | InChI=1S/C16H32O6/c1-2-3-4-5-6-7-8-9-10-21-16-15(20)14(19)13(18)12(11-17)22-16/h12-20H,2-11H2,1H3/t12-,13-,14+,15-,16?/m1/s1 |
InChI Key | JDRSMPFHFNXQRB-IWQYDBTJSA-N |
Canonical SMILES | CCCCCCCCCCOC1C(C(C(C(O1)CO)O)O)O |
Molecular Formula | C16H32O6 |
Wikipedia | decyl glucoside |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 320.426 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Complexity | 275.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B 4 O A A A A A A A A A A A A A A A A A A A A A A A A A A k A A A A A A A A A A A A A A A A G g A A C A A A C B S w g A M C C A A A B g A A A A A A A A A A A A A A A A A A A A A A A A A R E A I A A A A i Q A A F A A A H A A H A 4 K w A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 99.4 |
Monoisotopic Mass | 320.22 |
Exact Mass | 320.22 |
XLogP3 | None |
XLogP3-AA | 2.4 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 22 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB- | 0.5311 |
Human Intestinal Absorption | HIA- | 0.5967 |
Caco-2 Permeability | Caco2- | 0.7406 |
P-glycoprotein Substrate | Substrate | 0.6838 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7730 |
Non-inhibitor | 0.8709 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8330 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7706 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8441 |
CYP450 2D6 Substrate | Non-substrate | 0.8238 |
CYP450 3A4 Substrate | Non-substrate | 0.5586 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8661 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8839 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9200 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7443 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8685 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9235 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8624 |
Non-inhibitor | 0.6009 | |
AMES Toxicity | Non AMES toxic | 0.8908 |
Carcinogens | Non-carcinogens | 0.9490 |
Fish Toxicity | Low FHMT | 0.5899 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9725 |
Honey Bee Toxicity | High HBT | 0.6542 |
Biodegradation | Ready biodegradable | 0.7562 |
Acute Oral Toxicity | III | 0.5272 |
Carcinogenicity (Three-class) | Non-required | 0.7075 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.4197 | LogS |
Caco-2 Permeability | -0.3330 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.4828 | LD50, mol/kg |
Fish Toxicity | 2.4039 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.5603 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty acyl glycosides |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty acyl glycosides of mono- and disaccharides |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Fatty acyl glycoside of mono- or disaccharide - Alkyl glycoside - Hexose monosaccharide - Glycosyl compound - O-glycosyl compound - Monosaccharide - Oxane - Secondary alcohol - Acetal - Organoheterocyclic compound - Oxacycle - Polyol - Organooxygen compound - Primary alcohol - Hydrocarbon derivative - Organic oxygen compound - Alcohol - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. These are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol. |
From ClassyFire